Down 65%, Should You Buy the Dip on SoundHound AI Stock?
SoundHound AI ( NASDAQ: SOUN ) was a darling stock in 2024. At one point in late December, shares were up over 1,000% for the year, but then it sold off as investors took gains.That sell-off continued into 2025 and then reaccelerated as AI stocks in general sold off over economic fears caused by ...
Serve Robotics Saddles Up for Autonomous Delivery in Dallas-Fort Worth Via Uber Eats - Serve Robotics ( NASDAQ:SERV ) , Uber Technologies ( NYSE:UBER )
DALLAS, April 03, 2025 ( GLOBE NEWSWIRE ) -- Serve Robotics Inc. ( "Serve" ) SERV, a leading autonomous sidewalk delivery company, today announced the launch of its service in the Dallas-Fort Worth metro area. This strategic expansion, in continued partnership with Uber Eats-the delivery platform ...
MariMed's Betty's Eddies Expands Top-Selling Brand With Introduction of THC & CBG-Infused Caramel Chews - MariMed ( OTC:MRMD )
NORWOOD, Mass., April 03, 2025 ( GLOBE NEWSWIRE ) -- Betty's Eddies™, the all-natural cannabis chews handcrafted to fit a variety of needs, is expanding its lineup with the introduction of delicious caramel chews: Betty's Caramelt Away.
Crescent Biopharma Appoints Joshua Brumm as Chief Executive Officer and Expands Leadership Team to Advance Pipeline of Potentially Best-in-Class Oncology Therapeutics - GlycoMimetics ( NASDAQ:GLYC )
Jonathan McNeill, M.D., Appointed President and Chief Operating Officer Ellie Im, M.D., Appointed Chief Medical Officer Additional Leadership Appointments: Rick Scalzo, MBA, as Chief Financial Officer, and Amy Reilly, as Chief Communications Officer
RxSight Warns On FY25 Revenue As Premium Cataract Market Faces Headwinds, Stock Plunges - RxSight ( NASDAQ:RXST )
RxSight sees Q1 revenue up 28% YoY to $37.9M, but misses consensus of $40.14M. FY25 outlook lowered with revenue forecast cut to $160M-$175M, below consensus of $188.9M.
Alterity Therapeutics to Deliver an Oral Presentation of the Positive ATH434 Phase 2 Trial Results at the American Academy of Neurology Annual Meeting - Alterity Therapeutics ( NASDAQ:ATHE )
MELBOURNE, Australia and SAN FRANCISCO, April 03, 2025 ( GLOBE NEWSWIRE ) -- Alterity Therapeutics ( ATHATHE ( "Alterity" or "the Company" ) , a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that an oral presentation ...
Alterity Therapeutics to Deliver an Oral Presentation of the Positive ATH434 Phase 2 Trial Results at the American Academy of Neurology Annual Meeting
MELBOURNE, Australia and SAN FRANCISCO, April 03, 2025 ( GLOBE NEWSWIRE ) -- Alterity Therapeutics ( ASX: ATH, NASDAQ: ATHE ) ( "Alterity" or "the Company" ) , a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that an ...
MEXC to List StakeStone ( STO ) to Support Omnichain Liquidity Innovation with 130,000 USDT Airdrop+ Rewards
VICTORIA, Seychelles, April 03, 2025 ( GLOBE NEWSWIRE ) -- MEXC, a leading global cryptocurrency exchange, is excited to announce that it has listed StakeStone ( STO ) on both the spot and futures markets as of April 3, 2025 ( UTC ) .
Why SoFi Stock Fell 20% in March
SoFi Technologies ( NASDAQ: SOFI ) stock fell 20% in March according to data provided by S&P Global Market Intelligence. The market's been in turmoil due to President Donald Trump's tariff plans, and riskier growth stocks typically bear the brunt of volatility when the market's in flux.SoFi is an ...
